August 21, 2026
Strengthening the Vanguard: BCRF Appoints Tatiana Cancro and Kristen Manion Taylor to Board of Directors strengthening-the-vanguard-bcrf-appoints-tatiana-cancro-and-kristen-manion-taylor-to-board-of-directors

Strengthening the Vanguard: BCRF Appoints Tatiana Cancro and Kristen Manion Taylor to Board of Directors

Reynand Wu September 13, 2025 0
In a strategic move to bolster its leadership as the global fight against breast cancer enters a...
Read More Read more about Strengthening the Vanguard: BCRF Appoints Tatiana Cancro and Kristen Manion Taylor to Board of Directors
The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity the-life-and-legacy-of-dr-juliet-daniel-a-pioneer-in-cancer-research-and-champion-of-health-equity

The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity

Ammar Sabilarrohman September 11, 2025 0
The scientific community, McMaster University, and the global network of cancer researchers are mourning the profound loss...
Read More Read more about The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity
Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025 0
By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...
Read More Read more about Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation

Ammar Sabilarrohman August 13, 2025 0
A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...
Read More Read more about Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation
Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

Raul Delapena Setiawan August 13, 2025 0
Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...
Read More Read more about Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

You may have missed

the-complex-intersection-of-glp-1-medications-and-plastic-surgery-a-new-frontier-in-patient-safety

The Complex Intersection of GLP-1 Medications and Plastic Surgery: A New Frontier in Patient Safety

Ammar Sabilarrohman August 21, 2026
bridging-the-global-health-divide-wehis-breakthrough-rapid-diagnostic-for-iron-deficiency

Bridging the Global Health Divide: WEHI’s Breakthrough Rapid Diagnostic for Iron Deficiency

Nana Muazin August 21, 2026
navigating-the-uncharted-breast-cancer-survivors-share-wisdom-on-what-they-wish-theyd-known

Navigating the Uncharted: Breast Cancer Survivors Share Wisdom on What They Wish They’d Known

Lina Hope August 21, 2026
bridging-the-gap-roche-canada-and-pcpa-reach-landmark-agreement-for-perjeta-in-neoadjuvant-breast-cancer-treatment

Bridging the Gap: Roche Canada and pCPA Reach Landmark Agreement for Perjeta in Neoadjuvant Breast Cancer Treatment

Siti Muinah August 21, 2026